C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.45
0.10 (4.26%)
At close: Aug 15, 2025, 1:16 PM
C4 Therapeutics Fail-to-Deliver
Total FTD Shares
30.13K
Below Average
FTD / Avg. Volume
2.03%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 7, 2025,
C4 Therapeutics Inc. has
30,128
shares failed to deliver, representing 2.03%
of the average daily volume of
1,486,220
shares. Over the past year, the monthly average FTD is
31,585
shares, with the current level 5% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 07, 2025 | 1.52 | 30.13K | +3.24% |
| Jun 30, 2025 | 1.43 | 29.18K | +646.92% |
| May 29, 2025 | 1.32 | 3.91K | +2171.51% |
| Apr 28, 2025 | 1.62 | 172 | -93.41% |
| Mar 28, 2025 | 1.75 | 2.61K | -91.54% |
| Feb 18, 2025 | 2.97 | 30.87K | +1810.33% |
| Jan 31, 2025 | 3.47 | 1.62K | +910.00% |
| Dec 27, 2024 | 3.79 | 160 | -96.73% |
| Nov 27, 2024 | 4.55 | 4.9K | -61.35% |
| Oct 18, 2024 | 6.35 | 12.67K | +1212.85% |
| Sep 30, 2024 | 5.7 | 965 | +4095.65% |
| Aug 26, 2024 | 6.93 | 23 | -99.99% |
| Jul 29, 2024 | 6.54 | 183.6K | +201659.34% |
| Jun 26, 2024 | 4.63 | 91 | -98.31% |
| May 29, 2024 | 4.99 | 5.4K | +193.74% |
| Apr 30, 2024 | 6.3 | 1.84K | +474.38% |
| Mar 27, 2024 | 8.05 | 320 | -77.24% |
| Feb 27, 2024 | 9.75 | 1.41K | -96.16% |
| Jan 31, 2024 | 6.18 | 36.65K | -9.99% |
| Dec 29, 2023 | 5.65 | 40.71K | +75290.74% |
| Nov 28, 2023 | 1.57 | 54 | -97.15% |
| Oct 31, 2023 | 1.49 | 1.9K | +1564.04% |
| Sep 27, 2023 | 1.81 | 114 | -95.83% |
| Aug 11, 2023 | 3.41 | 2.73K | +60.88% |
| Jul 31, 2023 | 3.89 | 1.7K | +507.14% |
| Jun 30, 2023 | 2.75 | 280 | -75.78% |
| May 31, 2023 | 3.39 | 1.16K | +51.51% |
| Apr 28, 2023 | 3.02 | 763 | +116.76% |
| Mar 31, 2023 | 3.14 | 352 | -97.70% |
| Feb 28, 2023 | 5.27 | 15.34K | +167.85% |
| Jan 30, 2023 | 7.78 | 5.73K | n/a |